Mirae Asset Global Investments Co., Ltd. Biotechnology

Mirae Asset Global Investments Co., Ltd.

$37.3 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
HUMA Humacyte, Inc.	$249M	$7,000 0.0% of portfolio	4,136	Q1 2025 Reduced 3.54%
ITOS I Teos Therapeutics, Inc.	$365M	$7,000 0.0% of portfolio	1,222	Q1 2025 Added 0.41%
TERN Terns Pharmaceuticals, Inc.	$213M	$7,000 0.0% of portfolio	2,842	Q1 2025 Added 0.42%
ACIU Ac Immune Sa	$173M	$6,000 0.0% of portfolio	3,309	Q1 2025 Added 0.39%
ANNX Annexon, Inc.	$111M	$6,000 0.0% of portfolio	3,567	Q1 2025 Added 0.42%
CRVS Corvus Pharmaceuticals, Inc.	$200M	$6,000 0.0% of portfolio	2,048	Q1 2025 Reduced 4.34%
FHTX Foghorn Therapeutics Inc.	$254M	$6,000 0.0% of portfolio	1,861	Q1 2025 Added 0.43%
VYGR Voyager Therapeutics, Inc.	$124M	$6,000 0.0% of portfolio	1,828	Q1 2025 Added 0.44%
YMAB Y M Abs Therapeutics, Inc.	$189M	$6,000 0.0% of portfolio	1,505	Q1 2025 Added 0.8%
LXRX Lexicon Pharmaceuticals, Inc.	$255M	$5,000 0.0% of portfolio	12,096	Q1 2025 Added 0.42%
LYEL Lyell Immunopharma, Inc.	$2.36B	$5,000 0.0% of portfolio	9,776	Q1 2025 Added 5.06%
TNGX Tango Therapeutics, Inc.	$604M	$5,000 0.0% of portfolio	3,733	Q1 2025 Added 4.27%
THRD Third Harmonic Bio, Inc.	$219M	$5,000 0.0% of portfolio	1,508	Q1 2025 Added 0.4%
FDMT 4 D Molecular Therapeutics, Inc.	$141M	$4,000 0.0% of portfolio	1,533	Q1 2025 Reduced 0.45%
ALEC Alector, Inc.	$138M	$4,000 0.0% of portfolio	3,316	Q1 2025 Added 1.62%
LRMR Larimar Therapeutics, Inc.	$144M	$4,000 0.0% of portfolio	2,085	Q1 2025 Reduced 1.93%
NKTX Nkarta, Inc.	$97.3M	$4,000 0.0% of portfolio	2,330	Q1 2025 Reduced 0.94%
SCPH Sc Pharmaceuticals Inc.	$133M	$4,000 0.0% of portfolio	1,674	Q1 2025 Added 0.36%
SLN Silence Therapeutics PLC	$223M	$4,000 0.0% of portfolio	1,573	Q1 2025 Added 0.45%
CCCC C4 Therapeutics, Inc.	$107M	$3,000 0.0% of portfolio	2,375	Q1 2025 Added 0.98%
EDIT Editas Medicine, Inc.	$188M	$3,000 0.0% of portfolio	2,722	Q1 2025 Reduced 1.05%
ENTA Enanta Pharmaceuticals Inc	$150M	$3,000 0.0% of portfolio	714	Q1 2025 Added 1.13%
FATE Fate Therapeutics Inc	$112M	$3,000 0.0% of portfolio	3,942	Q1 2025 Added 3.87%
BMEA Biomea Fusion, Inc.	$55.1M	$2,000 0.0% of portfolio	1,230	Q1 2025 Added 1.82%
MGNX Macrogenics Inc	$94.6M	$2,000 0.0% of portfolio	2,100	Q1 2025 Added 0.43%
PLRX Pliant Therapeutics, Inc.	$69.1M	$2,000 0.0% of portfolio	2,036	Q1 2025 Added 0.39%
TCRX T Scan Therapeutics, Inc.	$35.6M	$2,000 0.0% of portfolio	1,556	Q1 2025 Reduced 4.89%
APLT Applied Therapeutics Inc.	$22.1M	$1,000 0.0% of portfolio	3,819	Q1 2025 Reduced 1.5%
IGMS Igm Biosciences, Inc.	$36.8M	$1,000 0.0% of portfolio	1,077	Q1 2025 Reduced 5.19%
INZY Inozyme Pharma, Inc.	$161M	$1,000 0.0% of portfolio	2,054	Q1 2025 Reduced 4.06%
MRSN Mersana Therapeutics, Inc.	$35M	$1,000 0.0% of portfolio	4,134	Q1 2025 Added 0.41%
PEPG Pep Gen Inc.	$28.8M	$1,000 0.0% of portfolio	1,021	Q1 2025 Reduced 5.99%
PYXS Pyxis Oncology, Inc.	$41.8M	$1,000 0.0% of portfolio	1,990	Q1 2025 Added 0.4%
STRO Sutro Biopharma, Inc.	$40.2M	$1,000 0.0% of portfolio	2,676	Q1 2025 Reduced 2.62%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	3,252	Q1 2025 Added 0.4%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.